Harmony Gold Mining reports 61% operating profit surge but output decline and copper capex weigh on HMY stock
Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
Read More 5 minute read Pharma Industry News What makes Aptar Pharma’s latest nasal drug delivery bet a potential market disruptor? Aptar Pharma teams up with Dianosic to advance a bioresorbable nasal scaffold platform for chronic sinus and rhinitis care. Find out how this could reshape treatment. byPallavi MadhirajuSeptember 6, 2025